Shingles Vaccine Shingrix Linked to Lower Dementia Risk in Older US Adults
• An analysis of 1.5 million Medicare beneficiaries showed older US adults receiving the recombinant subunit zoster vaccine (Shingrix) were less likely to develop dementia. • Published findings from MedPage Today on May 5, 2026, highlight the vaccine's potential protective effect against dementia in seniors. • This matters as it suggests vaccination could reduce dementia incidence amid rising Alzheimer's cases, a leading cause of excess US deaths per Boston University research.
ama-assn.org
